LongTerm Outcomes in Systemic SclerosisAssociated Pulmonary Arterial Hypertension

Figure 1 CHEST 2018 154862 -871 DOI: (10. 1016/j. chest. 2018. 05. 002) Copyright

Figure 2 CHEST 2018 154862 -871 DOI: (10. 1016/j. chest. 2018. 05. 002) Copyright

Slides: 3

Long-Term Outcomes in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS) Kathleen D. Kolstad, MD, Ph. D, Shufeng Li, MS, Virginia Steen, MD, Lorinda Chung, MD Marcy B. Bolster, MD, Mary Ellen Csuka, MD, Chris T. Derk, MD, Robyn T. Domsic, MD, Aryeh Fischer, MD, Tracy Frech, MD, Richard Furie, MD, Daniel Furst, MD, Avram Z. Goldberg, MD, Mardi Gomberg-Maitland, MD, Jessica Gordon, MD, Faye Hant, DO, Nicholas Hill, MD, Monique Hinchcliff, MD, Evelyn Horn, MD, Laura Hummers, MD, Vivien Hsu, MD, Susanna Kafaja, MD, Firas Kassab, MD, Dinesh Khanna, MD, Thomas A. Medsger, MD, Ioana Preston, MD, Jerry Molitor, MD, Ph. D, Lesley Saketkoo, MD, Lee Shapiro, MD, Elena Schiopu, MD, Rick Silver, MD, Robert Simms, MD, John Varga, MD, Frederick Wigley, MD CHEST Volume 154 Issue 4 Pages 862 -871 (October 2018) DOI: 10. 1016/j. chest. 2018. 05. 002 Copyright © 2018 American College of Chest Physicians Terms and Conditions